Mesothelioma Trials: Oral PXD101

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

The international biotech company Topo Target A/S is currently seeking patients diagnosed with cancers such as mesothelioma, lymphoma or solid tumors to participate in a study of a drug known as PXD101.

The focus of the Phase I trial is to study the tolerability and safety of the drug for cancer patients, as well as examining the drug’s effectiveness in treating tumors.

The study is being conducted at Yale New Haven Hospital in New Haven, Connecticut; Columbia University-Herbert Irving Cancer Center in New York City and the M.D. Anderson Cancer Center in Houston, Texas. The study is also being conducted at research facilities in Denmark and England.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.